Barclay Pearce Capital
- Aug 4, 2023
- 2 min read
Wellnex Life's Investor Highlights - Corporate Showcase Interview
Hear Zack Bozinovski, Managing Director of Wellnex Life outline the company story, investor highlights and the strategy over the next 6 to 12 months.
Investor Highlights:
- 100%-owned pharmaceutical brands - Mr. Bright, Wakey Wakey, Nighty Night, The Iron Company Pharmacy Own ranges in all major Pharmacy and Grocery retailers.
- IP-Licensing and contract manufacturing agreements with Haleon (formerly known as GlaxoSmithKline) to use Wellnex’s intellectual property (Dossier) for soft-gel analgesic product range in Australia and New Zealand, which recently has been expanded to the UK, Ireland and UAE.
- Two Joint Ventures with Chemist Warehouse for Australia’s first liquid paracetamol soft gel range under Wagner Health Liquigesics and the launch of Medicinal Cannabis products under the SAS-B market.
- Growing portfolio of Intellectual Property to support new innovative product launches.
- Growing revenue and increasing margins with revenue growing 51% in FY23 compared to FY22 and budgeted to grow a further 68% in FY24 putting the Company on pathway to profitability.
To learn more about Wellnex Life or access investor opportunities, register your interest below.
Share Link